FDA applicant
Micrus Endovascular Corporation
FDA records 23 decisions for Micrus Endovascular Corporation (San Jose, CA) from 2005 to 2011: 23 510(k) clearances. Most are in product codes HCG (Device, Neurovascular Embolization) and DQO (Catheter, Intravascular, Diagnostic). Its devices cite 45 predicates, 21 of them its own earlier devices. 2 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Micrus Endovascular Corporation’s devices, and how often a recall has named them.
FDA decisions per year
1in 2011
2026 so far, outlined.
Recalls per year
1in 2010
Class I Class II/III not classified
Planning a device like Micrus Endovascular Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Micrus”
FDA records each applicant name separately; these may or may not be the same firm.